Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

WFNOS Magazine

The inaugural issue of the official publication of the World Federation of Neuro-Oncology Societies is ...

Read Full Story

Neuro-Oncology Review Course at SNO

November 16, 2016. Register in conjunction with the SNO Annual Meeting

Read Full Story

CNS Anticancer Drug Discovery and Development Conference

Register Now!

Read Full Story
View All News

October
12

EANO 2016

Read Full Story

October
22

18th Annual Brain Tumor Update and 7th Annual International Symposium on Long-Term Control of Metastases to the Brain and Spine

Read Full Story

November
16

2nd CNS Anticancer Drug Discovery/Development Conference

Read Full Story

Education Day, November 17, 2016

 

The 2016 Education Day will offer innovative and informative presentations on Translational Science, Clinical and Applied Neuro-Oncology. The overall Education Day theme will focus on Precision Medicine and the new WHO Classification of central nervous system tumors. The day begins with a joint plenary session featuring two keynote speakers followed by concurrent sessions in the areas of Precision Medicine Research and Applied Neuro-Oncology. Highlights include the new WHO classification updates and molecular diagnosis of brain tumors, clinical trials in the era of precision medicine, current topics in ethics of patient consent and genomics, diagnostic approaches in liquid biopsy and immuno-oncology, and fatigue and cognitive dysfunction interventions. Also included will be presentations on precision medicine and its implication in meningioma, pediatric gliomas, surgery and radiation. The two groups will reconvene for an exciting afternoon session featuring mock integrative diagnostic and treatment tumor boards with practical tips on how to better incorporate precision medicine into neuro-oncology practice.

 

CO-CHAIRS

Manmeet Ahluwalia, MD, Cleveland Clinic
Jaishri Blakeley, MD, Johns Hopkins University
Kristina Hardy, PhD, Children's National Medical Center
Keith Ligon, MD, PhD, Dana-Farber Cancer Institute

 

Confirmed speakers:

PRECISION MEDICINE SESSION

  • KEYNOTE: Malcolm A. Smith, MD, PhD, National Cancer Institute: Precision medicine in cancer
  • Brian Alexander, MD, MPH, Dana-Farber Cancer Institute: Clinical trials in the era of precision medicine
  • Chetan Bettegowda, MD, Johns Hopkins University: Liquid biopsy in precision medicine
  • Daniel Brat, MD, PhD, Emory University: IDH-omas
  • Prakash Chinnaiyan, MD, Beaumont Health:  Radiation in the era of precision medicine
  • Cynthia Hawkins, MD, PhD, The Hospital for Sick Children: Pediatric gliomas
  • Frederick Lang, MD, MD Anderson Cancer Center: Surgical interventions in the era of precision medicine
  • Arie Perry, MD, University of California, San Francisco: WHO in practice and precision medicine
  • David L. Rimm, MD, PhD, Yale University: Immuno-oncology diagnostics in cancer
  • Sandro Santagata, PhD, MD, Brigham and Women's Hospital: Meningiomas

APPLIED NEURO-ONCOLOGY SESSION

  • KEYNOTE: Margaret Foster Riley, JD, University of Virginia: How “big data” may change ethical practice, research, and privacy 
  • Arash Asher, MD, Cedars-Sinai Medical Center: Inflammation cytokines and cancer-related fatigue/cognitive dysfunction
  • David Cachia, MD, Medical University of South Carolina: Interventions for fatigue and cognitive dysfunction in people with gliomas
  • Jennifer Cahill, PhD, Massachusetts General Hospital:  Personal health records, symptoms, uncertainty, and mood in brain tumor patients
  • Jorg Dietrich, MBA, MD, PhD, Massachusetts General Hospital: Translation of pre-clinical models to clinical interventions for radiation-associated cognitive injury
  • Steven Keating,  BSc, Massachusetts Institute of Technology: Informed consent in the era of big data
  • Karin S. Walsh, PsyD, George Washington University Medical Center: Individual cognitive dysfunction risk-based models based on the new classification

MOCK MOLECULAR TREATMENT TUMOR BOARD SPEAKERS

  • Jan Buckner, MD, Mayo Clinic
  • Lola B. Chambless, MD, Vanderbilt University
  • Martin van den Bent, MD, Erasmus MC Cancer Center
  • Arnab Chakravarti, MD, Ohio State University
  • Moderator: Manmeet Ahluwalia

MOCK DIAGNOSTIC TUMOR BOARD SPEAKERS

  • Joanna Phillips, MD, PhD, University of California, San Francisco
  • Robert Jenkins, MD, PhD, Mayo Clinic
  • Nikolaus Schultz, PhD, Memorial Sloan-Kettering Cancer Center
  • Moderator: Keith Ligon